| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $860.2M | +12.6% |
| R&D Expense | $63.8M | +29.5% |
| SG&A Expense | $263.9M | +126.1% |
| Operating Income | -$62.4M | -176.5% |
| Pre-tax Income | -$114.6M | -336.4% |
| Income Tax | -$4.3M | -138.8% |
| Net Income | -$110.3M | -395.7% |
| EPS (Basic) | -$0.74 | -384.6% |
| EPS (Diluted) | -$0.74 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $168.7M | -21.1% |
| Accounts Receivable | $266.8M | +87.0% |
| Current Assets | $476.0M | +27.4% |
| Total Assets | $3.92B | +140.6% |
| Current Liabilities | $250.7M | +194.8% |
| Long-term Debt | $2.16B | +283.0% |
| Total Liabilities | $2.62B | +261.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $28.2M | -82.7% |
| Capital Expenditures | $1.7M | -17.5% |
| Investing Cash Flow | -$1.65B | -2371.3% |
| Financing Cash Flow | $1.58B | +678.0% |
| Free Cash Flow | $26.5M | -83.5% |
| -384.6% |
| Stockholders' Equity |
| $1.31B |
| +44.1% |